Personalized Medicine

AI Platform Recommends Lower, More Personalized Chemotherapy Doses

by Shania Kennedy

Researchers from the National University of Singapore (NUS) have shown that that an artificial intelligence (AI) platform designed to recommend optimal chemotherapy doses from cancer patients achieved...

How Unified Patient Records Support Whole-Person Care

by Erin McNemar, MPA

Last year, Franciscan Health, a 14-hospital system with facilities in Indiana, Illinois, and Michigan partnered with Innovaccer to create unified patient records to support whole-person care. Whole-person care is a strategy that allows...

AI Company Launches Remote Care Service for Chronic Conditions

by Erin McNemar, MPA

Biofourmis, a Boston-based company focused on artificial intelligence-driven virtual care and digital therapeutics, has launched Bioformis Care, a service that aims to deliver high-quality remote care...

UNC Researchers To Lead NIH Precision Nutrition Centers

by Erin McNemar, MPA

 The University of North Carolina (UNC) at Chapel Hill will play an important role in the National Institutes of Health's (NIH) new study on precision nutrition. UNC received two of 14 awards...

NIH Researchers Develop Personalized Breast Cancer Therapy Approach

by Erin McNemar, MPA

National Cancer Institute researchers have revealed an experimental form of immunotherapy that uses a patient’s tumor-fighting immune cells to treat those with metastatic breast cancer, advancing...

Blood Biomarkers Can Help Determine Post-Pregnancy Depression 

by Erin McNemar, MPA

Michigan-based researchers found that signs of inflammation in blood could predict and identify severe depression during and after pregnancy, promoting precision medicine efforts. By...

How Can Artificial Intelligence Change Medical Imaging?  

by Erin McNemar, MPA

Increasingly, researchers are looking for ways to implement artificial intelligence into medical imaging. There are several different cases for why a patient might need medical imaging. Whether it’s for a cardiac event, fracture,...

Limiting Bias in Artificial Intelligence Tools, Personalized Medicine

by Erin McNemar, MPA

As more research looks to use medical data for artificial intelligence tools and personalized medicine, a new study shows how unintentional bias can impact design efforts. Additionally, the study...

Triple-Negative Breast Cancer Biomarker A Potential Therapy Target

by Erin McNemar, MPA

Boston University School of Medicine researchers have discovered a metabolic enzyme and pathway in some triple-negative breast cancer (TNBC) patients. According to researchers, the hope is that their...

Using Genetic Data For Developing Personalized Cancer Therapies

by Erin McNemar, MPA

Indiana University researchers launched a new study to create personalized therapy for patients with triple-negative breast cancer based on genetic data. According to researchers, risk stratification...

Genetic Signatures Predict Outcomes, Advance Personalized Treatment

by Erin McNemar, MPA

Baylor College of Medicine researchers have discovered a genetic signature that can predict poor patient outcomes in estrogen-receptor positive (ER+) breast cancer, potentially leading to personalized...

Advancing Personalized Treatment For Throat Cancer Patients

by Erin McNemar, MPA

University of California researchers are studying how to advance personalized treatment for patients with HPV-associated oropharyngeal cancer. The research led by Robert Chin, MD, PhD, a radiation...

Breast Cancer Database to Support Personalized Medicine

by Erin McNemar, MPA

To develop personalized treatment solutions for patients with breast cancer, UC San Diego Health received a $2.1-million gift to launch a comprehensive breast cancer database. Philanthropists Richard...

Predictive Analytics, Genetic Biomarkers Determine Treatment Response

by Erin McNemar, MPA

Using predictive analytics, a genetic biomarker test can determine how men with high-risk prostate cancer will respond to treatment and deliver more personalized medicine. In the study, researchers...

Advancing Personalized Medicine For Ventricular Arrhythmias

by Erin McNemar, MPA

To better understand ventricular arrhythmias, Johns Hopkins University researchers are studying the use of whole-heart computational models. Whole-heart computational modeling can lead to personalized...

Using Artificial Intelligence to Detect Anti-cancer Immunity

by Erin McNemar, MPA

UT Southwestern Medical Center and the University of Texas MD Anderson Cancer Center researchers developed an artificial intelligence method to determine anti-cancer immunity. According to...

Deep Learning Model Could Predict Outcomes for HCC Patients

by Erin McNemar, MPA

Cleveland Clinic researchers collaborated with Owkin to develop and validate a deep learning model to predict survival and outcomes for hepatocellular carcinoma (HCC) patients after liver...

How Does Artificial Intelligence Compare to Augmented Intelligence?

by Erin McNemar, MPA

As providers strive to improve patient outcomes, the use of machine learning has become more integrated into the healthcare system. As this new form of technology continues to expand, it’s...

How Proteins in Acute Myeloid Leukemia Support Precision Medicine

by Erin McNemar, MPA

Sanford Burnham Prebys Medical Discovery Institute scientists discovered that the protein RNF5 plays an unusual role in acute myeloid leukemia (AML). By targeting the specific protein, researchers...

Why Genetic Testing Is Key to Advancing Precision Medicine

by Erin McNemar, MPA

Due to genetics, not every patient responds the same to medications. With genetic testing, providers can better determine the best treatment options for individuals, advancing precision...